We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma (GLYRad)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02364206
Recruitment Status : Completed
First Posted : February 18, 2015
Last Update Posted : August 14, 2019
Sponsor:
Collaborators:
National Cancer Institute, France
ARC Foundation for Cancer Research
Information provided by (Responsible Party):
Centre Jean Perrin

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2019
Actual Study Completion Date : August 2019